Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.52 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.47 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.47 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.47 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.46 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.45 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL921276 | 0.81 | CYP3A4 (0.54) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL921552 | 0.80 | CYP3A4 (0.53) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL920822 | 0.76 | CYP3A4 (0.54) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL920506 | 0.76 | CYP3A4 (0.54) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL21332740 | 0.75 | LIPG (0.56) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL920459 | 0.74 | LIPG (0.55) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL920343 | 0.73 | KMT2A (0.61) | CYP3A4MAPK14PTGER4LIPGPTGER2 | |
| SCHEMBL920665 | 0.72 | GALR3 (0.54) | CYP3A4MAPK14PTGER4PTGER2L3MBTL1 | |
| SCHEMBL922348 | 0.71 | MAPK14 (0.55) | CYP3A4MAPK14CHRM4 | |
| SCHEMBL920779 | 0.71 | LIPG (0.51) | CYP3A4MAPK14PTGER4LIPGPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009454-A1 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-01-13 | — | — | US | disclosed |
| EP-2248423-A1 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009454-A1 | COMPOSITION FOR AGRICULTURAL USE FOR CONTROLLING OR PREVENTING PLANT DISEASES CAUSED BY PLANT PATHOGENS | WIZ, TST, NAT1 | CYP3A4 3076/4885MAPK14 905/4885PTGER4 3181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.